Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

The ACS has released cancer statistics for 2025 suggesting that more than 2 million new cases of cancer will be diagnosed in the US this year.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.

Cancer is a top killer in the United States, and Black women face the highest death rate and shortest survival of any racial or ethnic group.

Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new report.

Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, cancer incidence is statistically equivalent between women and men, at 832.5 and 830.6 cases per 100,000 people, respectively.

Drinking damages the body's DNA, leading to cancerous tissue growth. The safest option is to avoid consumption, experts say.

The Mississippi state and US federal governments are failing to take steps to prevent cervical cancer deaths for Black women in the Mississippi Delta, the Southern Rural Black Women’s Initiative for Economic and Social Justice (SRBWI) and Human Rights Watch said in a report released today during cervical cancer awareness month.

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands of percent.

AstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has approved the supplemental biologics license application (sBLA) seeking approval for expanded use of Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer in the United States.

WASHINGTON — President Trump unveiled a $500 billion artificial intelligence infrastructure project Tuesday at the White House alongside reps from three tech and investment giants — with those business leaders asserting the initiative could cure cancer.